On December 31, 2025, GridAI Technologies Corp. completed a significant asset disposition, unwinding its acquisition of ImmunogenX LLC, making it no longer a subsidiary. This transaction was previously reported in filings on March 25, 2025, and July 16, 2025, and included financial pro forma information annexed as Exhibit 99.1.